Drugs / Autologous Apheresis PRP Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07348315 | Sep 2023 → Sep 2025 | androgenetic alopecia | zhang li | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Apheresis PRP Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07348315 ↗ |
| Route | Subcutaneous | “PRP was administered via intradermal and subcutaneous injections at multiple points across the treatment area” NCT07348315 ↗ |